GC
BRLI

Guggenheim Capital’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Guggenheim Capital’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,786
Closed -$445K – 3101
2015
Q2 		$445K Buy
10,786
+4,208
+64% +$151K ﹤0.01% 2582
2015
Q1 		$232K Sell
6,578
-13,635
-67% -$461K ﹤0.01% 2760
2014
Q4 		$650K Buy
20,213
+10,034
+99% +$290K ﹤0.01% 2418
2014
Q3 		$285K Sell
10,179
-96
-0.9% -$2.92K ﹤0.01% 2739
2014
Q2 		$311K Sell
10,275
-183
-2% -$5.05K ﹤0.01% 2754
2014
Q1 		$289K Buy
10,458
+1,995
+24% +$52.2K ﹤0.01% 2758
2013
Q4 		$217K Sell
8,463
-37,755
-82% -$1.16M ﹤0.01% 2811
2013
Q3 		$1.38M Buy
46,218
+7,477
+19% +$208K 0.01% 1886
2013
Q2 		$1.11M Buy
+38,741
New +$1.07M ﹤0.01% 1968

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Guggenheim Capital's BRLI Position: Q3 2015 in Review

Guggenheim Capital sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 10,786 shares — an estimated $445K sold.

Guggenheim Capital first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $1.38M in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Guggenheim Capital reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Guggenheim Capital sold 10,786 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $445K.
  • Guggenheim Capital first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Guggenheim Capital's BIO-REFERENCE LABS INC-NEW- position peaked at $1.38M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Guggenheim Capital's 13F filing for Q3 2015, filed 16 Nov 2015.